Your browser doesn't support javascript.
loading
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.
Corvigno, Sara; Mezheyeuski, Artur; De La Fuente, Laura Martin; Westbom-Fremer, Sofia; Carlson, Joseph W; Fernebro, Josefin; Åvall-Lundqvist, Elisabeth; Kannisto, Paivi; Hedenfalk, Ingrid; Malander, Susanne; Rolny, Charlotte; Dahlstrand, Hanna; Östman, Arne.
Afiliação
  • Corvigno S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Electronic address: sara.corvigno@ki.se.
  • Mezheyeuski A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • De La Fuente LM; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University and Skåne University Hospital, Lund, Sweden.
  • Westbom-Fremer S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University and Skåne University Hospital, Lund, Sweden.
  • Carlson JW; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Fernebro J; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Åvall-Lundqvist E; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Kannisto P; Department of Obstetrics and Gynecology, Skåne University Hospital, Sweden; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University and Skåne University Hospital, Lund, Sweden.
  • Hedenfalk I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University and Skåne University Hospital, Lund, Sweden.
  • Malander S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University and Skåne University Hospital, Lund, Sweden; Department of Oncology, Skåne University Hospital, Sweden.
  • Rolny C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Dahlstrand H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Östman A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Gynecol Oncol ; 159(3): 860-868, 2020 12.
Article em En | MEDLINE | ID: mdl-33032823
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Antígeno CD11c / Carcinoma Epitelial do Ovário / Macrófagos Associados a Tumor Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Antígeno CD11c / Carcinoma Epitelial do Ovário / Macrófagos Associados a Tumor Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article